2 nd AROME MONTENEGRO COURSE: BRIDGE BETWEEN SCIENCE AND CLINICS IN ONCOLOGY

Transcription

1 2 nd AROME MONTENEGRO COURSE: BRIDGE BETWEEN SCIENCE AND CLINICS IN ONCOLOGY 1 st AROME ESO JOINT CONSENSUS CONFERENCE: ACCESS TO CANCER CARE INNOVATIONS IN EMERGING COUNTRIES Conference Presidency: Joseph GLIGOROV AROME President Vladimir TODOROVIC Director of Oncology & radiotherapy clinic, Clinical Center of Montenegro, University of Montenegro Matti AAPRO European School of Oncology (ESO) Sharing Progress in Cancer Care Department coordinator Scientific Committee: Matti Aapro (Switzerland), Joseph Gligorov (France). Vladimir Todorovic (Montenegro), Yazid Belkacemi (France), Semir Beslija (Bosnia & Hercegovina), Franco Cavalli (Switzerland), Michele De Laurentis (Italy), Zoran Dzamic (Serbia), Radan Dzodic (Serbia), Djoko Jocic (Montenegro), Ahmed Khalil (France), Khaldoun Kerrou (France), Vladimir Kovcin (Serbia), Abraham Kuten (Israel), Jadranka Lakićević (Montenegro), Ranko Lazovic (Montenegro), Nenad Mijalkovic (Serbia), Daniela Miladinova (Macedonia), Giorgio Mustacchi (Italy), Goran Nikolic (Montenegro), Davorin Radosavljevic (Serbia), Sinisa Radulovic (Serbia), Milan Ristevski (Macedonia), Ljiljana Stamatović (Serbia), Zoran Tomasevic (Serbia), Zorica Tomasevic (Serbia), Dusanka Tesanovic (Serbia), Paula Tsoutsou (Greece), Sedat Turkan (Turkey), Suzana Vasovic (Serbia), Filip Vukmirovic (Montenegro), Jean Jacques Zambrowski (France), Bojan Zaric (Serbia) Organization: ASTAKOS Travel Club Jadranski put 16; Budva Montenegro Tel: ; Fax: ; e mail: officebd@astakos.com

2 2 nd AROME MONTENEGRO COURSE: BRIDGE BETWEEN SCIENCE AND CLINICS IN ONCOLOGY 7 th October :00 14:30 Welcome and Introduction 14:30 15:00 Rational and objectives of the course and consensus conference (J. Gligorov) 15:00 19:00 Session 1: Innovations in diagnostics and locoregional therapies. (Chairs: S. Knezevic Usaj; F. Vukmirovic; N. Radosevic) 15:00 15:30 Innovations in Oncopathology and Molecular diagnostics (F. Vukmirovic) 15:30 16:00 Indications for molecular diagnostics in (S. Radulovic) 16:00 16:15 Discussion 16:15 16:45 Coffee break 16:45 17:15 Innovations in PET CT imaging in oncology (K. Kerrou) 17:15 17:30 Indications for PET CT in (D. Miladinova) 17:30 17:45 Discussion 17:45 18:15 Innovation in Radiotherapy (A. Kuten) 18:15 18:45 Indications for new radiotherapy techniques in (S. Maric) 18:45 19:00 Discussion

3 8 th October :00 09:45 AROME presidential lecture: Costs of cancers treatments innovations: future challenges (J. J. Zambrowski) 09:45 10:15 Coffee break 10:15 13:20 Session 2: Innovations in cancer systemic treatments (part 1). (Chairs: J. Gligorov, M. De Laurentis, V. Kovcin) 10:15 10:45 Colo rectal cancers treatments: Innovations, indications and access in (V. Kovcin) 10:45 11:15 Non colo rectal GI cancers treatments: Innovations, indications and access in (N. Mijalkovic) 11:15 11:30 Discussion 11:30 12:00 HER2 positive breast cancers: Innovations, indications and access in (J. Gligorov) 12:00 12:30 HR positive breast cancers treatments: Innovations, indications and access in (Z. Tomasevic) 12:30 13:00 Triple negative breast cancers treatments: Innovations, indications and access in (M. De Laurentis) 13:00 13:20 Discussion 13:20 14:30 Lunch break

4 14:30 15:50 Session 3: Innovations in cancer systemic treatments (part 2) (Chairs: S. Turkan; P. Tsoutsou; N. Cicmil) 14:30 15:00 Non squamous cell lung cancers treatments: Innovations, indications and access in (D. Radosavljevic) 15:00 15:30 Squamous cell lung cancers and Mesothelioma treatments: Innovations, indications and access in (B. Zaric) 15:30 15:50 Discussion 16:00 16:30 Coffee break 16:30 19:30 Educational programs sessions sponsored 16:30 18:30 Breast Cancer: bridge between science and oncology (Roche) 18:30 19:30 Optimizing survival in advanced prostate cancer (Sanofi Aventis) 9 th October :00 09:45 ESO presidential lecture: Innovations in lymphoid neoplasias (F. Cavalli) 09:45 11:15 Session 4: Economic actors of innovations access (round table) (Chairs: J. J. Zambrowski, J Gligorov, V Todorovic, A Kuten) 11:15 11:35 Coffee break 11:35 13:30 Session 5: Innovations in cancer systemic treatments (part 3) (Chairs: Z. Dzamic, S. Beslija, M. Ristevski) 11:35 11:55 Malignant melanomas: Innovations, indications and access in emerging countries (V. Todorovic) 11:55 12:15 Basal Cell Carcinomas: Innovations, indications and access in emerging countries (A. Kuten) 12:15 12:30 Discussion

5 12:30 12:50 Ovarian cancers treatments: Innovations, indications and access in (L. Stamatovic) 12:50 13:10 Other Gynecological malignancies treatments: Innovations, indications and access in (S. Vasovic) 13:10 13:30 Discussion 13:30 14:00 Educational programs sessions sponsored 13:30 14:30 Optimizing the mrcc continuum of care (Pfizer) 14:30 15:00 Lunch break 15:00 16:30 Session 5: Innovations in cancer systemic treatments (part 4) (Chairs: Z. Dzamic, S. Beslija, M. Ristevski) 15:00 15:20 Renal cell cancers treatments: Innovations, indications and access in (Z. Dzamic) 15:20 15:40 Prostate cancers treatments: Innovations, indications and access in (J. Lakicevic) 15:40 16:00 Other GU: Innovations, indications and access in (A. Khalil) 16:00 16:15 Discussion 16:15 16:30 Coffee break 16:30 19:30 Educational programs sessions sponsored 16:30 17:30 Finding the best treatment options for patients with mcrc (Merck) 17:30 18:30 Progress in the treatment of advanced NSCLC (Astra Zeneca) 18:30 19:30 Immunotherapy in oncology (MSD) 20:30 23:00 Conference dinner, BRUNO Restaurant in hotel Avala Budva All delegates are invited, bus leaves in front of hotel Mediteran at 20:15. Dress code: Smart casual

6 10 th October st AROME ESO JOINT CONSENSUS CONFERENCE: ACCESS TO CANCER CARE INNOVATIONS IN EMERGING COUNTRIES Panelist: Y. Belkacemi; N. Babovic; S. Beslija; F. Cavalli; N. Cicmil; M. De Laurentis; D. Tarifa Koroveshi; Z. Dzamic; R. Dzodic; J. Gligorov; S. Radulovic; D. Jocic; A. Khalil; K. Kerrou; V. Kovcin; A. Kristo Pema; A. Kuten; J. Lakicevic; R. Lazovic; N. Mijalkovic; D. Miladinova; G. Mustacchi; G. Nikolic; D. Radosavljevic; S. Radulovic; N. Radosevic; M. Ristevski; L. Stamatovic; P. Stefanovski; I. Stojkovski; D. Tesanovic; V. Todorovic; Z. Tomasevic; Z. Tomasevic; P. Tsoutsou; S. Turkan; S. Knezevic Usaj; S. Vasovic; F. Vukmirovic; B. Zaric. 08:45 09:00 Welcome and Introduction (Chairs: M. Aapro; F Cavalli; J. Gligorov; V. Todorovic) 09:00 09:15 Conclusions from the last ESO World Oncology Forum (F. Cavalli) 09:15 09:30 Oncology education: the main driver for access to innovation (R. Dzodic) 09:30 11:00 1 st AROME ESO joint consensus conference: access to cancer care innovations in (Part 1) 11:00 11:30 Coffee break 11:30 13:00 1 st AROME ESO joint consensus conference: access to cancer care innovations in (Part 2)